Cisen Pharmaceutical Co., Ltd. (SHA:603367)

Cisen Pharmaceutical Revenue

Cisen Pharmaceutical had revenue of 850.35M CNY in the quarter ending March 31, 2026, a decrease of -7.59%. This brings the company's revenue in the last twelve months to 3.37B, down -10.07% year-over-year. In the year 2025, Cisen Pharmaceutical had annual revenue of 3.44B, down -13.48%.

• Revenue (ttm): 3.37B
• Revenue Growth: -10.07%
• P/S Ratio: 1.99
• Revenue / Employee: 1.08M
• Employees: 3,114
• Market Cap: 6.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.44B	-536.86M	-13.48%
Dec 31, 2024	3.98B	-480.78M	-10.77%
Dec 31, 2023	4.46B	396.26M	9.75%
Dec 31, 2022	4.07B	283.50M	7.49%
Dec 31, 2021	3.78B	108.43M	2.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error